Antibody Engineering & Therapeutics US is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


M. Jack Borrok, PhD
Scientist II, Antibody Discovery and Protein Engineer at AstraZeneca


Dr. Borrok joined MedImmune in 2010 and currently works on a variety of antibody technologies focusing on the IgG Fc including antibody half-life extension, tissue targeting, modulating effector function, ADCs, and improving antibody developability.  Jack received his PhD in biochemistry from the University of Wisconsin-Madison and received post-doctoral training at The University of Texas at Austin, where he studied antibody & protease engineering, as well as the biology of the IgG Fc region.

Agenda Sessions

  • Improving Antibody Efficacy by Putting Antibodies at the Site of Action